Skip to content

Using Empowered Relief and Education To Help Postpartum Women Recover After Cesarean Delivery

A Pilot Feasibility Trial for a Comprehensive Multimodal Intervention to Assess Global Recovery Following Cesarean Delivery

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07192718
Enrollment
60
Registered
2025-09-25
Start date
2025-12-02
Completion date
2026-12-01
Last updated
2026-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications, Postpartum Care

Brief summary

The purpose of this study is to study the effect of a pain relief skills session (Empowered Relief) and educational content on global postpartum recovery at 12 weeks post cesarean delivery.

Interventions

The participants will attend a pain relief skills intervention (Empowered Relief). The two-hour session is delivered by a certified instructor and includes pain neuroscience education, 3 core pain management skills, experiential exercises, completion of a personalized plan for empowered relief. Participants download a binaural relaxation audio file for daily use.

OTHEREducation

Educational content: Participants view videos online focusing on specific areas of postpartum recovery (Sleep, Mental Health, Physical Therapy, Obstetric care).

Sponsors

Stanford University
Lead SponsorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Females 18 years of age or older * Any woman scheduled for a cesarean delivery in the Stanford Healthcare system with a viable birth * English fluency * Ability to adhere to and complete study protocols * Access to smart device for zoom / video meetings

Exclusion criteria

* \<18yrs * chronic pain prior to pregnancy * Cognitive impairment, non-English speaking, or psychological factors that would preclude comprehension of material and/or full participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of participants registering for Empowered Relief sessionBaseline (up to 2 weeks)
Percentage of participants attending Empowered Relief sessionTreatment (up to 2 weeks)
Empowered Relief: Participant Satisfaction Scale Score1 - 2 weeks Post treatmentParticipant satisfaction will be measured using a 7 item questionnaire (scale ranges from 0 - 42, higher ratings represent greater satisfaction with the treatment).
Empowered Relief: Participant Treatment Skills Use Scale ScoreWeek 3, Week 8, Week 14Participant treatment skills use will be measured with a 5 items questionnaire (scale ranges from 0 - 25, higher ratings represent increased time using treatment).
Percentage of participants watching educational contentTreatment (up to 2 weeks), Week 3
Educational content: Participant Satisfaction Scale Score1 - 2 weeks Post treatment, Week 3, Week 8, Week 14Participant satisfaction will be measured using a 7 item questionnaire with three scored items: overall usefulness (0-6), the usefulness rating of each module (0-6), and frequency of use (0-3). The composite score ranges from 0-15, with higher scores indicating greater satisfaction and use. Additional checklist and free-text items capture engagement but are not included in the score.

Secondary

MeasureTime frameDescription
Change from baseline in PROMIS Pain Interference 8a scale scoreBaseline, Week 3, Week 8, Week 14Participants complete Patient Reported Outcomes Measurement Outcomes System (PROMIS) Pain Interference 8a questionnaire, an 8-item scale assessing pain interference with life enjoyment, concentration, and daily activities over the past 7 days. (Score range 8 - 40, higher scores represent a greater degree of pain interference).
Change from baseline in PROMIS Pain Intensity 3a scale scoreBaseline, Week 3, Week 8, Week 14Participants complete PROMIS Pain Intensity 3a questionnaire, a 3-item scale assessing average pain intensity for the past 7 days. (Score range 3 - 15, higher score represents a greater degree of pain intensity)
Change from baseline in Pain Catastrophizing Scale ScoreBaseline, Week 3, Week 8, Week 14Participants complete Pain Catastrophizing questionnaire, a 13-item scale assessing an individual's pain experience (Score range 0 - 52, higher score represents a greater degree of pain catastrophizing)
Change from baseline in Pain Interference Scale Score via SMSBaseline through end of study (up to 14 weeks)Participants complete twice weekly questionnaire to assess pain interference via SMS. (Score range 0 - 10, higher score represents a greater degree of interference)
Response rate to Pain Interference scale score via SMSBaseline through end of study (up to 14 weeks)This outcome determines the percentage of participants responding to the twice weekly pain interference scale score via SMS text.
Change from baseline in PROMIS Sleep Disturbance 8a scale scoreBaseline, Week 3, Week 8, Week 14Participants complete Patient Reported Outcomes Measurement Outcomes System (PROMIS) Sleep Disturbance 8a questionnaire, an 8-item scale assessing self-reported perceptions of sleep quality, sleep depth, restoration, perceived difficulties and concerns with getting to sleep/staying asleep, as well as perceptions of the adequacy and satisfaction with sleep over the past 7 days. (Score range 8 - 40, higher scores represent a greater degree of sleep disturbance).
Change from baseline in STanford Obstetric Recovery checKlist (STORK) scale scoreBaseline, Week 2, Week 3, Week 8, Week 14Participants complete the STORK questionnaire, a 47-item scale assessing postpartum recovery over the past 7 days. (Score range 0 - 188, higher score represents a greater degree of recovery)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORPervez Sultan

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026